-
GEN – Genetic Engineering & Biotechnology News2 weeks agoXaira’s First Virtual Cell Model Is Largest To-Date, Toward Complex Biology
Billion dollar-backed AI drug developer, Xaira Therapeutics, has recently released the largest virtual cell model to-date to predict how cells respond to genetic perturbations in unseen biological contexts. The team asserts that accurately predicting transcriptome-level effects is a...
-
GEN – Genetic Engineering & Biotechnology News2 weeks ago
Genomic Mapping of E. coli Capsules Identifies High-Risk Types for Vaccines
A sweeping genomic survey is offering the clearest picture yet of how Escherichia coli uses its protective capsule to evade the immune system—and which capsule types...
-
GEN – Genetic Engineering & Biotechnology News2 weeks ago
Sanofi Steps Up Autoimmune Push with Up-to-$1.23B+ Kali Collaboration
Sanofi has agreed to license from Kali Therapeutics its lead tri-specific T-cell engager (TCE) antibody candidate KT501, which is being developed to treat a variety of...
-
GEN – Genetic Engineering & Biotechnology News2 weeks ago
Immunotherapy for Solid Tumors Enhanced by Metabolite-Sensing Receptors
In a new study published in Nature Immunology titled, “Engineering NK and T cells with metabolite-sensing receptors to target solid tumors”, researchers from Stanford University have developed an approach...
-
GEN – Genetic Engineering & Biotechnology News2 weeks ago
Glioblastoma Growth Mechanism Identified, Pointing to Potential Therapeutic Targets
A study led by Adelaide University scientists at the Centre for Cancer Biology (CCB) has uncovered a critical mechanism driving the growth and spread of glioblastoma (GBM)—one...
-
GEN – Genetic Engineering & Biotechnology News2 weeks agoJudge’s Halt on RFK Jr.’s Vaccine Changes Remains in Effect, At Least for Now
Brian Murphy, a U.S. District Judge in Massachusetts, recently temporarily blocked key parts of RFK Jr.’s plan to change the U.S. childhood vaccine schedule. Judge Murphy...
-
GEN – Genetic Engineering & Biotechnology News2 weeks agoModified Lipid Nanoparticles Boost mRNA Vaccine Delivery to Lymph Nodes
Lipid nanoparticles have become the workhorse of mRNA vaccines, ferrying genetic cargo into cells so the immune system can learn to recognize a threat. But most...
-
GEN – Genetic Engineering & Biotechnology News2 weeks ago
Synthetic DNA Manufacturing Hub Set Up in Boston by Artis BioSolutions
Artis BioSolutions, an advanced therapies company in San Diego, established new synthetic DNA manufacturing capabilities in Boston utilizing Bilbao, Spain-based Syngoi Technologies’ proprietary enzymatic platform. This...
-
GEN – Genetic Engineering & Biotechnology News2 weeks agoHIV Remains Suppressed in Some Patients After Treatment Withdrawal
For millions of people with HIV (PWH), a daily regimen of medications is a lifelong necessity. If they stop taking antiretroviral therapy (ART), the virus usually...
-
GEN – Genetic Engineering & Biotechnology News2 weeks ago
Skin Regeneration Enabled by Embryonic Healing Mechanism in Mice
In a new study published in Cell titled, “Hyperinnervation inhibits organ-level regeneration in mammalian skin,” researchers from Harvard University reveal a method to fully regenerate skin by unblocking an embryonic...
Sanofi Bispecific Scores in Asthma, Rhinosinusitis, but Eczema Bet Doesn’t Pay Off
